Medial EarlySign and Centric Consulting Join Forces to Increase Hospital Adoption of Clinical AI Solutions

Collaboration will Enable Hospitals to Identify and Prioritize Patients at Risk of High-Burden Diseases, Including COVID-19, Flu, Diabetes, and Other Conditions

Medial EarlySign, a leader in AI-based clinical data solutions to aid in the early detection and prevention of high-burden diseases, and leading management consulting firm Centric Consulting announced a partnership to enable US-based hospitals and healthcare organizations to utilize existing data in order to identify and prioritize patients for care.

Combining Centric’s leading consulting services with EarlySign’s clinically validated AI-powered solutions, the two companies will work together to help healthcare organizations utilize data-backed insights in order to prioritize patient procedures, deliver focused interventions and re-engage populations. EarlySign’s Infectious Disease bundle will be a primary focus, given the ongoing COVID-19 pandemic and imminent arrival of the next flu season.

Recommended AI News: Web3 Labs Recognized As A Finalist Of The Microsoft For Start Ups Award

“Assisting hospitals in navigating clinical, operational and technology adoption challenges and providing outcome-focused care has always been of utmost importance at Centric. We see tremendous value in EarlySign’s platform which utilizes machine learning technology to help our clients facilitate proactive and strategic interventions for patients at high risk of a range of serious medical conditions,” said Marcie Stoshak-Chavez, MD, National Healthcare Practice Lead of Centric. “EarlySign’s validated framework of clinical solutions is perfectly aligned to address our clients’ immediate and long-term artificial intelligence strategies.”

The partnership follows the recent launch of EarlySign’s Back2Care suite of clinical data solutions and will provide hospitals with the tools to identify and prioritize high-risk patients and re-engage populations. The suite offers several solutions aimed at high-burden diseases, including the Infectious Disease bundle, Admissions bundle, Diabetes + Complications bundle, and an Early Detection bundle for diseases such as lung and colorectal cancer. By utilizing routine medical data collected over the course of care and drawing clinical insights into the best course of action for patients, healthcare organizations can optimize resources to provide more personalized and focused care.

Recommended AI News: Exabeam Appoints Security Industry Veteran Adam Geller As Chief Product Officer

“Working collaboratively with Centric to help drive transformational change will allow us to further our goal of advancing proactive healthcare and keeping populations healthy,” said Jeremy Orr MD, CEO of Medial EarlySign. “We are looking forward to further expanding our reach by engaging with Centric’s broad network to support hospitals in improving patient outcomes and navigating the transition back to necessary screening and care.”